CL2013003268A1 - Uso de una composición que comprende secnidazol y un antibiótico macrólido para preparar un medicamento útil en el tratamiento de infecciones dentales. - Google Patents

Uso de una composición que comprende secnidazol y un antibiótico macrólido para preparar un medicamento útil en el tratamiento de infecciones dentales.

Info

Publication number
CL2013003268A1
CL2013003268A1 CL2013003268A CL2013003268A CL2013003268A1 CL 2013003268 A1 CL2013003268 A1 CL 2013003268A1 CL 2013003268 A CL2013003268 A CL 2013003268A CL 2013003268 A CL2013003268 A CL 2013003268A CL 2013003268 A1 CL2013003268 A1 CL 2013003268A1
Authority
CL
Chile
Prior art keywords
secnidazole
prepare
treatment
composition
medicament useful
Prior art date
Application number
CL2013003268A
Other languages
English (en)
Inventor
Pierre-Marie Defrance
Original Assignee
Vegefarm
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44352217&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=CL2013003268(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Vegefarm filed Critical Vegefarm
Publication of CL2013003268A1 publication Critical patent/CL2013003268A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CL2013003268A 2011-05-16 2013-11-14 Uso de una composición que comprende secnidazol y un antibiótico macrólido para preparar un medicamento útil en el tratamiento de infecciones dentales. CL2013003268A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR1101478A FR2975299B1 (fr) 2011-05-16 2011-05-16 Utilisation du secnidazole dans le traitement des infections dentaires

Publications (1)

Publication Number Publication Date
CL2013003268A1 true CL2013003268A1 (es) 2014-07-04

Family

ID=44352217

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2013003268A CL2013003268A1 (es) 2011-05-16 2013-11-14 Uso de una composición que comprende secnidazol y un antibiótico macrólido para preparar un medicamento útil en el tratamiento de infecciones dentales.

Country Status (15)

Country Link
US (1) US9700574B2 (es)
EP (1) EP2709617B1 (es)
KR (1) KR20140056179A (es)
CN (1) CN103596565B (es)
BR (1) BR112013028872B1 (es)
CL (1) CL2013003268A1 (es)
CO (1) CO6801770A2 (es)
ES (1) ES2562163T3 (es)
FR (1) FR2975299B1 (es)
MX (1) MX2013013339A (es)
PH (1) PH12013502335A1 (es)
PL (1) PL2709617T3 (es)
RU (1) RU2013150335A (es)
WO (1) WO2012156599A1 (es)
ZA (1) ZA201308025B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2959414C (en) 2014-09-05 2023-03-14 Symbiomix Therapeutics, Llc Secnidazole for use in the treatment of bacterial vaginosis
WO2016196653A1 (en) 2015-06-01 2016-12-08 Symbiomix Therapeutics, Llc Novel nitroimidazole formulations and uses thereof
US12280037B2 (en) 2020-09-22 2025-04-22 Evofem Biosciences, Inc. Method and pharmaceutical composition for treating or preventing trichomoniasis and uses thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7691831B2 (en) * 1999-03-17 2010-04-06 Ernest L. Bonner, Jr. Pharmaceutical combination and method for treatment of reactive arthritis or bursitis
CN1559428A (zh) * 2004-03-11 2005-01-05 金春华 一种含有塞克硝唑的根除幽门螺旋杆菌的复方药物

Also Published As

Publication number Publication date
EP2709617A1 (fr) 2014-03-26
WO2012156599A1 (fr) 2012-11-22
FR2975299B1 (fr) 2013-09-27
BR112013028872B1 (pt) 2020-01-28
EP2709617B1 (fr) 2015-11-25
BR112013028872A2 (pt) 2017-01-31
CN103596565A (zh) 2014-02-19
ES2562163T3 (es) 2016-03-02
KR20140056179A (ko) 2014-05-09
RU2013150335A (ru) 2015-06-27
CO6801770A2 (es) 2013-11-29
CN103596565B (zh) 2017-06-20
PL2709617T3 (pl) 2016-05-31
ZA201308025B (en) 2015-04-29
PH12013502335A1 (en) 2019-03-22
MX2013013339A (es) 2013-12-02
FR2975299A1 (fr) 2012-11-23
US20140080778A1 (en) 2014-03-20
US9700574B2 (en) 2017-07-11

Similar Documents

Publication Publication Date Title
CL2014001585A1 (es) Compuestos derivados de betulina; composicion farmaceutica; y el uso de los mismos en el tratamiento y prevencion de una infeccion por vih.
SMT201500148B (it) Composizioni per uso nel trattamento di infezioni virali
BR112013018953A2 (pt) composição efervescente na forma sólida para uso em aplicações vaginais para o tratamento de infecções vaginais.
CO6811867A2 (es) Cannabinoides para uso en el tratamiento del dolor neuropático
CL2014000370A1 (es) Hemifumarato de tenofovir alafenamida; metodo de preparación; composicion farmaceutica que lo comprende; metodo para preparar la composicion farmaceutica; y uso en el tratamiento de una infeccion por hiv.
BR112013011448A2 (pt) composto, composição farnmacêutica, e, uso do composto
BR112012022878A2 (pt) composto, composição farmacêutica, uso do compostos e método de tratamento
BR112012022879A2 (pt) composto, composição farmacêutica, uso do composto e método de tratamento
CL2014000470A1 (es) Compuestos derivados del acido 2-oxo-piridin-3-carboxilico; composicion farmaceutica; combinacion; y su uso para tratar o mejorar una infeccion bacteriana.
CL2014000732A1 (es) Compuestos derivados heterociclicos para su uso en la prevencion o tratamiento de una infeccion por flavivirus; metodo para su preparacion; y composicion farmaceutica que los comprende.
CL2014002093A1 (es) Compuestos derivados piperidinopirimidinicos; composicion farmaceutica que los comprende; uso en el tratamiento de infecciones viricas.
CL2013001296A1 (es) Inhibidor de fmo3, inhibidor de frk, modulador de lpar3, inhibidor de pde4d, inhibidor de camk1d, nicotinamida, roscovitina, remofovir, acetazolamida y luteolina, entre otros compuestos, para su uso en el tratamiento del dolor, tal como dolor cronico, agudo, dolor neuropatico, dolor inflamatorio y dolor artritico.
BR112014010177A2 (pt) composto, composição farmacêutica, uso do composto, e, método para a profilaxia ou tratamento de um estado ou uma condição de doença
BR112012031194A2 (pt) derivados de cisteamina e seu uso no tratamento de ehna
CL2015002755A1 (es) Composiciones antibióticas de ceftolozano.
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
MX2013012289A (es) Triazolopiridinas.
BR112013011693A2 (pt) derivados de ácido hidroxâmico e seu uso no tratamento de infecções por bactérias
BR112013030302A2 (pt) composto, composição farmacêutica, uso de um composto, combinação de um composto e dispositivo
CL2014002348A1 (es) Compuestos derivados de fenicol; composicion farmaceutica que los comprende; y su uso para controlar o tratar infecciones bacterianas en ganado.
BR112013014189A2 (pt) composição farmacêutica que compreende transcinamaldeíco e o uso da mesma no tratamento de infecções
CL2015003019A1 (es) Derivados biaromáticos antibacterianos
CO7061069A2 (es) Glucosaminoglucanos no anticogulantes que comprenden una unidad de repetición de disacárido y su uso médico
BR112014005406A2 (pt) composição de vacina e respectivo uso
CL2012001757A1 (es) Compuestos derivados de 8-hidroxiquinolina-7-carboxamida; composicion farmaceutica; y su uso en el tratamiento de infecciones micoticas.